baber/WOPTO huggingface dataset:
Patent AU-2003301897-B2 (AU)
Title: Disposable syringe with retractile needle
Inventor: ZEOLI FILOMENA
IPC: A61M5/32
Filed: 2003-07-10
Granted: 2008-04-24
Abstract: A disposable syringe having a double hook element (9), causing, after a piston stroke toward the end of the socket element (4) of the needle, allowing retraction within the reservoir (1) during the reverse stroke of the piston (2). A spring (8) between the double hook element (9) and the end of a reservoir lip, when compressed, maintains the double hook element (9) in its position, and when extended, acts to cause the return of the needle (5) within the reservoir (1).
Patent AU-2004208617-B2 (AU)
Title: Stable solid medicinal composition for oral administration
Inventor: NIWA AKIRA
IPC: A61P43/00
Filed: 2004-01-30
Granted: 2007-09-13
Abstract: This invention is aimed to provide a stabilized formulation of ramosetron or a pharmaceutically acceptable salt thereof under a temperature/humidity condition, especially at a low content and relates to a stable oral solid drug composition of ramosetron or a pharmaceutically acceptable salt thereof, which is characterized by containing one or two or more members selected from the group consisting of an aliphatic carboxylic acid or an ester thereof, a hydroxycarboxylic acid or an ester thereof, an acidic amino acid, an enolic acid, an aromatic carboxyl compound or an ester thereof, and a carboxyl group-containing high-molecular substance, and to a stabilization method of the same. Also, this invention relates to a therapeutic agent of diarrhea-predominant irritable bowel syndrome containing from 0.002 to 0.02 mg of ramosetron hydrochloride as a daily dose or an equivalent molar amount of ramosetron or its pharmaceutically acceptable other salt as an active ingredient.
Patent AU-2004235601-B2 (AU)
Title: Container
Inventor: DOMENICO GUALTIERI
IPC: B65D1/34
Filed: 2004-12-01
Granted: 2011-09-15
Abstract: Abstract Container A food container 1, e.g. for bakery products, is moulded from thermoplastic material and comprises a tray 2 and cover 3. The tray 2 and cover 3 are hinged together, and a label 15, e.g. a product identification label, is 10 taped across the tray 2 and cover 3 opposite to the hinge to seal the container closed. The tray 2 includes a wall member 6 that overlaps with an end region 12 of the cover 3 to such an extent that access to the container contents is substantially inhibited without breaking the label seal 15 or leaving a sign of access (e.g. buckling of the tray and/or cover). Thus, the container 1 is tamper resistant/tamper evident, and enables a greater confidence in the integrity of the contents. 20 [Fig. 1] H:\ju1ia1\keep\Speci\P55205.doc 30/11/04 Al 6b I'6 IHc 17- 17 6c 6 6b -66 77 Lij 7 2-2< iis
Patent AU-2004294254-B2 (AU)
Title: A soft capsule of butylphthalide and a process for preparing the same
Inventor: LI JIANQING
IPC: A61K31/34
Filed: 2004-12-03
Granted: 2008-02-07
Abstract: The present invention discloses a novel soft capsule of butylphthalide and a process for preparing the same. The soft capsule of butylphthalide is composed of a capsule wall material and a drug-containing oil, wherein the drug-containing oil is essentially composed of butylphthalide and a vegetable oil as the diluent in a weight ratio of about 1:0~10. The capsule wall material is composed of a capsule wall matrix, a plasticizer and water in a weight ratio of 1:0.2~0.4:0.8~1.3. The soft capsule of butylphthalide described in the present invention can mask the strong and special flavour of butylphthalide, and overcome the difficulties associated with formulating oily active ingredient into other oral formulation. The disintegration time of the soft capsule satisfies the requirement of Pharmacopoeia of P.R. China.
Patent AU-2005203055-B2 (AU)
Title: Sliding panel lock
Inventor: STEPHEN MOSS CHRISTOPHER
IPC: E06B3/42
Filed: 2005-07-14
Granted: 2011-07-14
Abstract: Abstract SLIDING PANEL LOCK A locking device (45) for a slidable panel (32) of a window or door assembly (31) comprising a spacer member (11') fixed to upper frame member (33) of the panel (32) and between the frame member (33) and head frame (37), a mounting bracket (12') engaged with the spacer member (It) and secured to the side frame member (35) of the panel (32) and a latching pin (26') on a resilient arm (23') integrally formed with the mounting bracket (12'), the latching pin (26') being engageable with a hole (43) in the head frame (37), the arm (23') being engageable by a releasing member (13') passed through a socket (19') on the spacer member (11') to allow retraction of the arm (23') and pin (26') to unlock the panel (32). 23' 37 39 43 434 26' 2\45
Patent AU-2005243427-B2 (AU)
Title: O-linked glycoforms of polypeptides and method to manufacture them
Inventor: KLAUSEN NIELS KRISTIAN
IPC: C12N9/64
Filed: 2005-05-03
Granted: 2010-07-22
Abstract: The present invention relates to compositions comprising glycoproteins having altered patterns of O-linked glycosylation, in particular Factor VII, Factor IX, and methods for making these.
Patent AU-2005251653-B2 (AU)
Title: The shine clade of transcription factors and their use
Inventor: ASAPH AHARONI
IPC: C12N15/82
Filed: 2005-06-09
Granted: 2011-10-20
Abstract: The present invention relates to the field of transgenic plants with given phenotypes, especially plants with enhanced drought tolerance. Provided are SHINE proteins and nucleic acid sequences encoding these, which are useful in conferring these phenotypes to plants.
Patent AU-2005256317-B2 (AU)
Title: Compositions comprising strontium and vitamin D and uses thereof
Inventor: HVARRE CHRISTENSEN JOHN NIKOLAJ
IPC: A61K33/24
Filed: 2005-06-24
Granted: 2011-09-15
Abstract: The invention relates to the finding that very favorable pharmacokinetic characters are obtained by combining two strontium salts in one pharmaceutical composition. The present invention relates in one aspect to a pharmaceutical composition comprising at least two strontium salts for use as a medicament, and in particular for the treatment and prevention of bone disorders such as osteoporosis. The composition preferably comprises strontium carbonate and strontium chlorides. Further included may be a vitamin D compound, preferably vitamin D
Patent AU-2005294615-B2 (AU)
Title: Track assembly for supporting fabrics
Inventor: MORRIS MILTON A
IPC: A47H23/00
Filed: 2005-09-29
Granted: 2012-01-19
Abstract: A track assembly for supporting fabric on a surface includes a base track defining a first half of a hinge and a first half of a snapping clamp. The base track preferably includes a tension force dissipater extending from the first half of the hinge. An upper track defines a second half of the hinge and is pivotally connectable to the base track. The upper track defines a second half of the snapping clamp for releasably engaging the fabric. The upper track includes a strut extended downwardly towards the base track such that when high tension forces are applied to the upper track, due to fabric tensioning, the strut contacts the base track and at least partially transmits the tension forces to the surface.
Patent AU-2005316802-B2 (AU)
Title: Method and system for catalytically converting oxygenates and regenerating and stripping catalyst
Inventor: SENETAR JOHN J
IPC: B01J38/12
Filed: 2005-12-02
Granted: 2011-09-15
Abstract: Oxigenate containing feedstocks are converted to light olefins in a process comprising charging a reactor (10) with catalyst, feeding the feedstock into the reactor (10), contacting the feedstock with the catalyst and converting the feedstock to olefins while depositing byproducts on the catalyst resulting in spent catalyst, regenerating the spent catalyst by contacting the catalyst with combustion gases, and stripping the regenerated catalyst of gases entrained in the regenerating step. The stripping step is accomplished using nitrogen gas to strip the entrained gases from the regenerated catalyst. In one embodiment, regenerated catalyst is passed through a regenerated catalyst stripper (70) before it is returned to the reactor.
Patent AU-2006201451-B2 (AU)
Title: Registration of ultrasound data with pre-acquired image
Inventor: ALTMANN ANDRES CLAUDIO
IPC: A61B5/296
Filed: 2006-04-06
Granted: 2012-09-20
Abstract: A system and method for imaging a target in a patient's body uses a pre 5 acquired image of the target and a catheter having a position sensor and an ultrasonic imaging sensor. The catheter is placed in the patient's body and positional information of a portion of the catheter in the patient's body is determined using the position sensor. The catheter is used to generate an ultrasonic image of the target using the ultrasonic imaging sensor. An image processor is used for determining 10 positional information for any pixel of the ultrasonic image of the target and registering the pre-acquired image with the ultrasonic image; and a display is used for displaying the registered pre-acquired image and ultrasonic image. 06/04/06,ck l5607apr6speci,2 Icc
Patent AU-2006259474-B2 (AU)
Title: Androgen receptor modulator compounds and methods
Inventor: LIN ZHI
IPC: A61P35/00
Filed: 2006-06-12
Granted: 2011-10-27
Abstract: Provided herein are compounds that bind to androgen receptors and/or modulate activity of androgen receptors, and to methods for making and using such compounds. Also provided are compositions including such compounds and methods for making and using such compositions.
Patent AU-2006263681-B2 (AU)
Title: A composition and its physical requirements for eliminating odors in air
Inventor: TASZ MACIEJ K
IPC: C09K23/42
Filed: 2006-06-28
Granted: 2011-09-22
Abstract: An air treating composition for eliminating odors from air in combination with specific spray valve and actuator requirements and spray performance parameters providing maximum dispersion of the active component in the composition into the air is disclosed. The particles of the composition are small so that the active component is dispersed into air as a fine dispersion to provide more contact with odors and to provide quick absorption of odors. The particle size of the composition is controlled through the selection of valve and actuator dimensions. The air treating and odor eliminating composition of the invention includes water, a low molecular weight polyol, an emulsifier, and a propellant. The composition may also include additional adjuvants such as solvent(s), fragrances(s), corrosion inhibitor, pH adjustor and the like.
Patent AU-2006276269-B2 (AU)
Title: Dispensing closure, package and method of manufacture
Inventor: PUGNE DARIN M
IPC: B65D47/20
Filed: 2006-07-14
Granted: 2012-03-22
Abstract: A dispensing closure includes a closure shell (30) of one-piece integrally molded plastic construction having a base (32) for securement to a container neck finish and a lid (34) coupled by a hinge (36) to the base. The base has a deck (38), a recess (46, 52) extending across the deck from a point adjacent to the hinge, and a dispensing opening (66) in the recess. The lid has a base portion (76) for receipt in the recess in the closed position of the lid and a tongue (82) at an end of the lid remote from the hinge. A latch (64, 84) on the base in the recess engages the tongue on the lid releasably to hold the lid in the closed position. The latch preferably comprises a snap latch that includes an internal bead (84) on the tongue and an external latch element (64) in the recess over which the internal bead is received in the closed position of the lid. The base preferably includes a ledge (54) in the recess against which the tongue abuts, and a pair of ribs (58, 60) for frictionally holding the tongue against the body.
Patent AU-2006291306-B2 (AU)
Title: Multi-layer, light markable media and method and apparatus for using same
Inventor: CLARK ROGER
IPC: B32B7/12
Filed: 2006-08-28
Granted: 2012-03-29
Abstract: A multi-layer laminate media is provided on which information may be applied in machine or human readable form on a visible front surface by the output of one or more lasers, or other high intensity light source. In a preferred embodiment, the media has three layers including a substrate, a thermochromic layer and a light absorbent layer located intermediate the media substrate and the thermochromic layer. The light absorbent layer is adapted to absorb light from the light source and convert the absorbed light into heat. The heat is immediately conducted into selected portions of the thermochromic layer which is in thermal contact with the light absorbent layer, causing portions of the thermochromic layer to change visual appearance such as color to create the desired mark. The media optimally includes obscuration materials to reduce the visibility of the light absorbent layer to the naked eye. The light absorbent layer is preferably a low cost absorber such as carbon black. An alternate form of the invention is a two layer laminate media including a substrate and a thermochromic layer. The invention is usable in conjunction with labeling produce items. The invention includes a method and apparatus for using media in conjunction with labeling produce items.
Patent AU-2006308778-B2 (AU)
Title: Article marking system
Inventor: MICHAEL GEORGE GEOFFREY
IPC: B60R25/00
Filed: 2006-10-25
Granted: 2011-11-10
Abstract: A method of marking an article. The method uses a control system to select one of a number of containers, each container having a fluid containing respective unique marking elements therein. The control system then generates control signals in accordance with the selected container before transferring the control signals to a manipulator. The manipulator is then responsive to the control signals to apply at least part of the fluid to the article to thereby marking the article with at least one marking element.
Patent AU-2006311274-B2 (AU)
Title: Dorsal adjusting multi-rod connector
Inventor: PERRA JOSEPH H
IPC: A61B17/70
Filed: 2006-11-06
Granted: 2010-06-24
Abstract: An orthopedic implant is disclosed having at least one passage for an elongated member that is compressible. In certain embodiments, multiple compressible elongated member passages may be provided, or an elongated member passage may be U-shaped and closable by a closure member. Split ring members may be provided in compressible passages and around elongated members. A bone anchor may be connected to the implant so that locking the anchor to the implant compresses one or more of the elongated member passages.
Patent AU-2007206901-B2 (AU)
Title: Long term treatment of HIV- infection with TCM278
Inventor: BAERT LIEVEN ELVIRE COLETTE
IPC: A61P31/18
Filed: 2007-01-19
Granted: 2013-01-31
Abstract: This invention relates to the use of a parenteral formulation comprising an anti-virally effective amount of TMC278 or a pharmaceutically acceptable acid-addition salt thereof, and a carrier, for the manufacture of a medicament for the treatment of a subject being infected with HIV, wherein the formulation is to be administered intermittently at a time interval of at least one week.
Patent AU-2007212696-B2 (AU)
Title: Hydrate forms of AMG706
Inventor: NEERVANNAN SESHADRI
IPC: A61P35/00
Filed: 2007-01-26
Granted: 2011-05-19
Abstract: The anti-angiogenic drug AMG 706 is provided in the mono-phosphate hydrate form. Also provided is AMG 706 drug substance wherein the AMG 706 is present, in at least a detectable amount, as AMG 706 phosphate dihydrate. Also provided are processes for preparing AMG 706 phosphate dihydrate, AMG 706 drug substance of the invention, and a pharmaceutical composition of the invention. Also provided is a method of treating a medical condition or disorder in a subject where treatment with an anti-angiogenic is indicated, comprising administering, for example orally, a composition of the invention in a therapeutically effective amount.
Patent AU-2007223903-B2 (AU)
Title: Humanized anti-CD22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease
Inventor: WILLIAMS DAVID G
IPC: A61K39/00
Filed: 2007-03-06
Granted: 2013-09-05
Abstract: The present invention provides chimeric and humanized versions of anti-CD22 mouse monoclonal antibody, HB22.7. The anti-CD22 antibodies of the invention comprise four human or humanized framework regions of the immunoglobulin heavy chain variable region ("VH") and four human or humanized framework regions of the immunoglobulin light chain variable region ("VK"). The invention further comprises heavy and/or light chain FW regions that contain one or more backmutations in which a human FW residue is exchanged for the corresponding residue present in the parental mouse heavy or light chain. Human or humanized VH framework regions of antibodies of the invention may comprise one or more of the following residues: a valine (V) at position 24 of framework region 1, a glycine (G) at position 49 of framework region 2, and an asparagine (N) at position 73 of framework region 3, numbered according to Kabat. The invention further relates to pharmaceutical compositions, immunotherapeutic compositions, and methods using therapeutic antibodies that bind to the human CD22 antigen and that preferably mediate human ADCC, CDC, and/or apoptosis for: the treatment of B cell diseases and disorders in human subjects, such as, but not limited to, B cell malignancies, for the treatment and prevention of autoimmune disease, and for the treatment and prevention of graft- versus-host disease (GVHD), humoral rejection, and post-transplantation lymphoproliferative disorder in human transplant recipients.
Patent AU-2007255448-B2 (AU)
Title: Prediction of rapid symptomatic blood pressure decrease
Inventor: SOLEM KRISTIAN
IPC: A61B5/00
Filed: 2007-06-04
Granted: 2012-08-23
Abstract: The invention relates to prediction of a rapid symptomatic drop in a subject's blood pressure, e.g. during a medical treatment or when operating an aircraft. To this aim, a pulse shape parameter (Pps) with respect to a peripheral body part (105) of the subject (P) is registered by means of a pulse oximetry instrument (110) adapted to detect light response variations in blood vessels. An initial pulse magnitude measure is calculated based on a pulse shape parameter (Pps) received at a first instance. During a measurement period subsequent to the first instance, a respective pulse magnitude measure is calculated based on each of a number of received pulse shape parameters (Pps). It is further investigated, for each pulse magnitude measure in the measurement period, whether or not the measure fulfils a decision criterion relative to the initial pulse magnitude measure. An alarm triggering signal (α) is generated if the decision criterion is found to be fulfilled.
Patent AU-2007257308-B2 (AU)
Title: Vaccine carrier
Inventor: GRONLUND HANS
IPC: A61K38/16
Filed: 2007-06-11
Granted: 2013-06-06
Abstract: The present invention relates to a hypoallergenic protein consisting of at least one hypoallergenic molecule derived from an allergen, which is fused or conjugated to at least one second non-allergenic protein or fragment thereof.
Patent AU-2007275101-B2 (AU)
Title: Needleless injection device with double stopper with low pressure profiles
Inventor: ALEXANDRE PATRICK
IPC: A61M5/30
Filed: 2007-06-26
Granted: 2013-02-21
Abstract: The present invention relates to a needleless injection device (1) comprising a reservoir (3), obturated by an upstream stopper (4) and a downstream stopper (5) between which a liquid active principle (6) is accommodated, and a receptacle (7) comprising at least one injection conduit (8), said receptacle comprising a cavity (10) whose height is equal to the distance travelled by the downstream stopper before each injection conduit is opened, - the height of the cavity in millimetres being between a minimum height and a maximum height, respectively defined by the following relationships, • minimum height = 3, • maximum height = 15 x exp. (-(V/9)
Patent AU-2007280690-B2 (AU)
Title: Nucleic acid of formula (I): GIXmGn, or (II): CIXmCn, in particular as an immune-stimulating agent/adjuvant
Inventor: HOERR INGMAR
IPC: C12N15/117
Filed: 2007-07-31
Granted: 2012-04-05
Abstract: The present invention relates to a nucleic acid of the general formula (I): GXG, or (II): CXC, which may be modified by a lipid. The nucleic acid of the invention acts as an immune-stimulating agent inducing the innate immune response. The invention relates further to a pharmaceutical composition (in a first embodiment), each containing an immune-stimulating agent according to the invention in combination with a pharmaceutically active carrier/vehicle (and, optionally, further auxiliary substances, additives and/or further adjuvants). In another embodiment, the inventive nucleic acid is combined with at least one pharmaceutically active component, a pharmaceutically acceptable carrier/vehicle (and, optionally, further auxiliary substances, additives and/or further adjuvants). Accordingly, the presemt invention is directed to a vaccine, which corresponds to a pharmaceutical composition of the invention (second embodiment), wherein the pharmaceutically active component induces a specific immune response (e.g. an antigen). The present invention relates likewise to the use of a nucleic acid of the invention or a pharmaceutical composition according to the invention for the treatment of infectious diseases, autoimmune diseases, allergies or cancer diseases.
Patent AU-2007309287-B2 (AU)
Title: Detecting ice particles
Inventor: SEVERSON JOHN A
IPC: B64D15/20
Filed: 2007-09-24
Granted: 2010-09-16
Abstract: Systems and methods for detecting ice particle accumulation is disclosed herein. In one exemplary implementation, a method for detecting ice is described in which a parameter within an interior volume of a heated conduit is measured. The method also includes detecting the presence of an accumulation of ice particles based on the parameter measured within the interior volume of the heated conduit.
Patent AU-2007332902-B2 (AU)
Title: Spreading layer and humidity control layer for enhancing sensor performance
Inventor: HE HUARUI
IPC: G01N33/52
Filed: 2007-12-06
Granted: 2012-04-26
Abstract: The invention is directed to optical sensors for measuring clinically relevant analytes, their methods of manufacture, and their various uses. In an effort to develop a dry calibration method for the optical sensors of the invention it is discovered that water content inside or in the immediate vicinity of a such a sensor can have a major impact on fluorescence intensity (i.e., a sensor's response in the dry state). Thus, one of the objectives of the invention is the elimination of the bias of sensor responses measured at different humidity environments.
Patent AU-2008202300-B2 (AU)
Title: Sprayable dry wash and wax composition and method of using same
Inventor: SEROBIAN ASHOT
IPC: C09G1/04
Filed: 2008-05-26
Granted: 2013-11-14
Abstract: A composition for simultaneously cleaning and waxing non-porous surfaces without the need for additional rinsing of the treated surface with water, has a pH of from about 6 to about 7 and contains by weight: (a) from about 0.04 to about 0.12 % of an acrylic-based polymer, wherein the acrylic-based polymer is a hydrophobically modified, crosslinked polyacrylate powder which has been crosslinked with a polyalkenyl polyether or is an acrylic polymer containing acid groups and which dissolves and swells immediately when neutralized with an alkali salt (b) from about 0.5 to about 5.0% of a silicone blend composed of: (i) from about 70 to about 95% of a first polydiorganosiloxane fluid having a viscosity of from about 0.65 to about 60,000 centistokes at 25*C., and (ii) from about 5 to about 30% of a polydiorganosiloxane fluid mixture having a viscosity of from about 500 to about 2000 centistokes at 25*C., the polydiorganosiloxane fluid mixture being composed of a second polydiorganosiloxane fluid and a silicone resin; (c) wax; and (d) water. The composition can be used to simultaneously clean and wax non-porous surfaces such as the exterior surfaces of automobiles and other vehicles, windows, and the like.